Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

More than 1% of U.S. children between the ages of 2 and 18 had “extremely severe obesity” in 2023 — a 250% increase from 2008 ...

So Wegovy’s approval by the FDA may open up a whole new avenue of possible approaches to managing obesity and overweight conditions. Other GLP-1-like treatments are already under development.

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Man injects weight loss drug. getty. On Friday, June 4 th, the Food and Drug Administration (FDA) approved Novo Nordisk’s obesity drug Wegovy (semaglutide), a glucagon-like peptide 1 receptor ...

Health Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure ...

Wegovy’s Popularity Is Now Sparking A Debate On The Causes Of Obesity The internet had * thoughts * after a 60 Minutes segment said genetics is to blame. By Amelia Harnish Published: Jan 27 ...

Wegovy is about to go mainstream. A wild idea recently circulated about the future of aviation: If passengers lose weight via obesity drugs, airlines could potentially cut down on fuel costs.

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Wegovy is part of a new class of injectable medications for obesity. On Wednesday, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound, a version of the diabetes drug Mounjaro ...